1i22: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:
|PDB= 1i22 |SIZE=350|CAPTION= <scene name='initialview01'>1i22</scene>, resolution 1.80&Aring;
|PDB= 1i22 |SIZE=350|CAPTION= <scene name='initialview01'>1i22</scene>, resolution 1.80&Aring;
|SITE=  
|SITE=  
|LIGAND= <scene name='pdbligand=CA:CALCIUM ION'>CA</scene>
|LIGAND= <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>
|ACTIVITY= [http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17]  
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span>
|GENE=  
|GENE=  
|DOMAIN=
|RELATEDENTRY=[[1lz1|1LZ1]], [[1i1z|1I1Z]], [[1i20|1I20]], [[2lhm|2LHM]], [[3lhm|3LHM]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1i22 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1i22 OCA], [http://www.ebi.ac.uk/pdbsum/1i22 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1i22 RCSB]</span>
}}
}}


Line 14: Line 17:
==Overview==
==Overview==
Structural determinants of Ca2+ binding sites within proteins typically comprise several acidic residues in appropriate juxtaposition. Three residues (Ala-83, Gln-86, and Ala-92) in human lysozyme are characteristically mutated to Lys, Asp, and Asp, respectively, in natural Ca2+ binding lysozymes and alpha-lactalbumins. The effects of these mutations on the stability and Ca2+ binding properties of human lysozyme were investigated using calorimetry and were interpreted with crystal structures. The double mutant, in which Glu-86 and Ala-92 were replaced with Asp, clearly showed Ca2+ binding affinity, whereas neither point mutant showed Ca2+ affinity, indicating that both residues are essential. The further mutation of Ala-83 --&gt; Lys did not affect the Ca2+ binding of the double mutant. The point mutations Ala-83 --&gt; Lys and Glu-86 --&gt; Asp did not affect the stability, whereas the mutation Ala-92 --&gt; Asp was about 1.3 kcal/mol less stable. Structural analyses showed that both Asp-86 and Lys-83 were exposed to solvent. Side chains of Asp-86 and Asp-91 were rotated in opposite directions about chi1 angle, as if to reduce the electrostatic repulsion. The charged amino acids at the Ca2+ binding site did not significantly affect stability of the protein, possibly because of the local conformational change of the side chains.
Structural determinants of Ca2+ binding sites within proteins typically comprise several acidic residues in appropriate juxtaposition. Three residues (Ala-83, Gln-86, and Ala-92) in human lysozyme are characteristically mutated to Lys, Asp, and Asp, respectively, in natural Ca2+ binding lysozymes and alpha-lactalbumins. The effects of these mutations on the stability and Ca2+ binding properties of human lysozyme were investigated using calorimetry and were interpreted with crystal structures. The double mutant, in which Glu-86 and Ala-92 were replaced with Asp, clearly showed Ca2+ binding affinity, whereas neither point mutant showed Ca2+ affinity, indicating that both residues are essential. The further mutation of Ala-83 --&gt; Lys did not affect the Ca2+ binding of the double mutant. The point mutations Ala-83 --&gt; Lys and Glu-86 --&gt; Asp did not affect the stability, whereas the mutation Ala-92 --&gt; Asp was about 1.3 kcal/mol less stable. Structural analyses showed that both Asp-86 and Lys-83 were exposed to solvent. Side chains of Asp-86 and Asp-91 were rotated in opposite directions about chi1 angle, as if to reduce the electrostatic repulsion. The charged amino acids at the Ca2+ binding site did not significantly affect stability of the protein, possibly because of the local conformational change of the side chains.
==Disease==
Known diseases associated with this structure: Amyloidosis, renal OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=153450 153450]], Microphthalmia, syndromic 1 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=309800 309800]]


==About this Structure==
==About this Structure==
Line 27: Line 27:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Kuroki, R.]]
[[Category: Kuroki, R.]]
[[Category: CA]]
[[Category: calcium binding site]]
[[Category: calcium binding site]]
[[Category: hydrolase]]
[[Category: hydrolase]]
[[Category: mutant human lysozyme]]
[[Category: mutant human lysozyme]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 11:44:29 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:13:31 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA